The document summarizes an upcoming conference on digital transformation in healthcare hosted by the Society of Investment Professionals in Germany. The 10th DVFA Life Science Conference will focus on challenges and opportunities around digital transformation in healthcare, with explosive growth in health data driving momentum in the digitalization of the healthcare sector. The conference will provide insights into topics like network medicine, electronic health records, medical apps/cloud computing, and EU data protection rules, with panels on new business models and capital market perspectives in digital health. It will feature industry experts as speakers and is aimed at professionals in life sciences, healthcare, and related fields.

1. Society of Investment Professionals in Germany
Digital Transformation in Healthcare
13 June 2017
DVFA Center, Frankfurt am Main
10th DVFA Life Science Conference
Supported by
Media Partner
Schnee Research
Plattform
Life Sciences
Networking Partner

2. The 10th DVFA Life Science Conference focuses on the challenges and opportunities of Digital Transformation in Healthcare. With
the explosive growth in health and biomedical data the digital transformation of the healthcare sector is gaining momentum.
Get insights in Network medicine, Telematics Infrastructure, Electronic Health Records (EHR), Medical Apps & Cloud, EU data
protection rules and discuss the future of digital medicine with industry experts.
u Topics
 Digital Transformation in Healthcare: Challenges & Opportunities
 The Telematics Infrastructure: The coming eHealth Revolution in Germany
 Connected Diabetes Management
 Increased data protection and data security requirements under the new EU Data Protection Regulation
 Panel Discussion – New Business Models Digital Health
 Next Generation Sequencing & Big Data
 The Health Revolution – Better Outcomes with Smart Data
 Panel Discussion – Digital Health: A Capital Market Perspective
 Digital Health – Startup-Slam
u Speakers & Moderators
 Dr. Christa Bähr, CEFA, CFA, Founder and Business Owner, CB HealthCare
 Kai Brüning, CEFA, Fundsmanager, apoAsset Management GmbH
 Eric Cohen, IR, Cellnovo Group
 Dr. Lothar Ende, Partner, HEUKING KÜHN LÜER WOJTEK
 Ralf Frank, Secretary General and Managing Director, DVFA
 Jason Gammack, Vice President Head of Marketing Life Sciences, QIAGEN N.V.
 Dr. Lutz Martin Keppeler, Senior Associate, Certified Specialist Lawyer for Information Technology Law,
HEUKING KÜHN LÜER WOJTEK
 Prof. Dr. Dr. Gerhard Lingg PhD, Chairman, imi mHealth Solutions Ltd.
 Dr. med. Markus Manns, Chairman DVFA Life Science Commission, Equities Fund Manager, Union Investment
Privatfonds GmbH
 Klaus May, Geschäftsführer, Genomatix
 Dr. Martin Pöhlchen, Partner, Alira Health
 Philip Pogoretschnik, CEO & Founder, Humanoo
 Karlheinz Schmelig, Managing Partner, Creathor Venture
 Carsten Schmitt, Investment Banking, Renell Bank
 Dr. Julia Schüler, CBA, Investor Relations, SynapCon
 Julian Shapley, CSO, Cellnovo Group
 Dr. Clemens Suter-Crazzolara, VP Product Management, Health, SAP SE
 Dr. Klaus Suwelack, New Venture Lead Germany, Johnson & Johnson Innovation/Janssen
 Christian B. Teig, CFO, CompuGroup Medical
 Lesli Wagstaffe, CEO, imi mHealth Solutions Ltd.
u Target group
The conference is geared to company representatives, sector specialists, life science experts as well as practicians
and experts from research institutions.
u Participation
By invitation only. Participation is free of charge.
u Venue
DVFA Center, Mainzer Landstraße 37-39, 60329 Frankfurt am Main, Germany
Tel.: +49 (0) 69 24 24 94 08
LIFE SCIENCE_
Conference 13 June 2017, 9 a.m.
Invitation_

3. LIFE SCIENCE
DVFA LIFE SCIENCE CONFERENCE_
08:45 a.m . u Check-in
09:00 a.m. u Welcome
Dr. Christa Bähr, CEFA, CFA, Chairwoman DVFA Life Science Commission,
CB HealthCare
Ralf Frank, Secretary General and Managing Director, DVFA
09:10 a.m. u Digital Transformation in Healthcare – Challenges & Opportunities
Dr. Martin Pöhlchen, Partner, Alira Health
09:45 a.m. u The Telematics Infrastructure: The Coming eHealth Revolution in Germany
Christian B. Teig, CFO, CompuGroup Medical
10:20 a.m. u Connected Diabetes Management
Julian Shapley, CSO, and Eric Cohen, IR, Cellnovo Group
10:50 a.m. u Coffee Break
11:10 a.m. u Increased Data Protection and Data Security Requirements under the
New EU Data Protection Regulation
Dr. Lothar Ende, Partner, and Dr. Lutz Martin Keppeler, Senior Associate,
Certified Specialist Lawyer for Information Technology Law, HEUKING
KÜHN LÜER WOJTEK
11:45 a.m. u Panel I: New Business Modells Digital Health
• Dr. Lutz Martin Keppeler, Senior Associate, Certified Specialist Lawyer for
Information Technology Law, HEUKING KÜHN LÜER WOJTEK
• Dr. Martin Pöhlchen, Partner, Alira Health
• Karlheinz Schmelig, Managing Partner, Creathor Venture
• Christian B. Teig, CFO, CompuGroup Medical
• Moderation: Dr. Klaus Suwelack, New Venture Lead Germany, Johnson &
Johnson Innovation/Janssen
12:45 p.m. u Lunch
01:30 p.m. u Next Generation Sequencing & Big Data
Jason Gammack, Vice President Head of Marketing Life Sciences, QIAGEN N.V.
02:05 p.m. u The Health Revolution – Better Outcomes with Smart Data
Dr. Clemens Suter-Crazzolara, VP Product Management, Health, SAP SE
02:40 p.m. u Coffee Break
03:00 p.m. u Panel II: Digital Health - A Capital Market Perspective
• Kai Brüning, CEFA, Fundsmanager, apoAsset Management GmbH
• Prof. Dr. Dr. Gerhard Lingg PhD, Chairman, imi mHealth Solutions Ltd.
• Carsten Schmitt, Investment Banking, Renell Bank
• Dr. Clemens Suter-Crazzolara, VP Product Management, Health, SAP SE
• Moderation: Dr. med. Markus Manns, Chairman DVFA Life Science
Commission, Equities Fund Manager, Union Investment Privatfonds
GmbH
04:00 p.m. u Digital Health - Startup-Slam
• Genomatix: Klaus May, Geschäftsführer
• Humanoo: Philip Pogoretschnik, CEO & Founder
• imi mHealth Solutions Ltd.: Lesli Wagstaffe, CEO
• SynapCon: Dr. Julia Schüler, CBA, Investor Relations
• Moderation: Karlheinz Schmelig, Managing Partner, Creathor Venture
04:45 p.m. u Get-together
Programme 13 June 2017
Subject to modifications

4. DVFA
Michael Kolb
Tel.: +49 (0)69 264848 130
Fax: +49 (0)69 264848 489
Mail: konferenzen@dvfa.de
Content: DVFA
Photos: www.shutterstock.com Subject to modifications. Copyright 2017 DVFA e.V.
Members of the DVFA Life Science Commission
Sascha Alilovic, MorphoSys AG, Martinsried/Planegg
Dr. Christa Bähr, CEFA, CFA, Chairwoman, CB HealthCare, Berlin
Dr. Viola Bronsema, BIO Deutschland e.V., Berlin
Kai Brüning, apo Asset Management GmbH, Düsseldorf
Ines-Regina Buth, CBA, akampion, Berlin
Dr. Ralf Emmerich, European Investment Fund, Luxemburg
Andreas Heinrichs, Bank Vontobel Europe AG, Köln
Stefan Höfer, Deutsche Börse AG, Eschborn
Dr. Kai Gregor Klinger, RHÖN-KLINIKUM AG, Bad Neustadt a.d. Saale
Dr. jur. Dr. med. Adem Koyuncu, COVINGTON & BURLING LLP, Brüssel
Dr. Solveigh Karola Mähler, MC SERVICES AG, Düsseldorf
Dr. med. Markus Manns, Chairman, Union Investment Privatfonds GmbH, Frankfurt
Dr. Markus Metzger, STADA Arzneimittel AG, Bad Vilbel
Dr. Marie-Luise Roth, DIB Deutsche Industrievereinigung Biotechnologie, Frankfurt
Dr. Martin Schnee, CBA, CCrA, Schnee Research, Maintal
Dr. Julia Schüler, CBA, BioMedServices, Darmstadt
Prof. Dr. Joerg Vienken, Nephro-Solutions AG, Hamburg
DVFA – Society of Investment Professionals in Germany
DVFA is the Society of Investment Professionals in Germany, founded in 1960. Currently,
DVFA has more than 1,400 individual members representing over 400 investment firms,
banks, asset managers, consultants and counselling businesses. DVFA assures the
credibility of the professionals and the integrity of the market by offering internationally
recognised qualification programmes, by providing platforms for professional financial
communication, and by effective self-regulation.
Via EFFAS, the umbrella organisation of European Analysts Societies, DVFA offers access
to a pan-European network with more than 17,000 investment professionals in 27 nati-
ons. Via ACIIA, the Association of Certified International Investment Analysts, DVFA is
part of a worldwide network of more than 100,000 investment professionals.